Prognostic relevance of TROP2 expression in patients with non-small cell lung cancer receiving immunotherapy

Abstract Trophoblast surface antigen 2 (TROP2) is strongly expressed in patients with non-small cell lung cancer (NSCLC), and its overexpression is closely associated with a worse prognosis. Recently, a novel TROP2-directed antibody–drug conjugate (ADC) has been developed, and TROP2 has been identif...

Descripció completa

Dades bibliogràfiques

Autors principals:	Naohito Hashimoto, Shota Takei, Kyoichi Kaira, Hisao Imai, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Ou Yamaguchi, Atsuto Mouri, Kunihiko Kobayashi, Mei Hamda, Hiroshi Kagamu
Format:	Artigo
Idioma:	Inglês
Publicat:	Nature Portfolio 2025-10-01
Col·lecció:	Scientific Reports
Matèries:	TROP2 PD-1 CTLA4 Lung cancer Resistance Prognosis
Accés en línia:	https://doi.org/10.1038/s41598-025-19362-3
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!